PTS, Inc. Signs Agreement to Provide Point-of-Care Lipid Testing to Life Line Screening
INDIANAPOLIS, Sept. 6, 2012 /PRNewswire/ -- Polymer Technology Systems, Inc. (PTS), the U.S.- based manufacturer of the CardioChek family of point-of-care diagnostic products, has announced the signing of a multiyear agreement to supply the CardioChek PA test system to Life Line Screening, a leading global provider of community-based preventive health screenings .
The CardioChek test system provides on-site lipid panel screening, which includes total cholesterol, HDL cholesterol, triglycerides, and LDL (calculated), as well as glucose, and delivers the results in less than two minutes.
According to Life Line Screening's Laboratory Medical Director, Benjamin Gerson, MD, "PTS is an ideal partner for us. Life Line Screening is certified under the CLIA federal mandate with a Certificate of Compliance, and as such, our focus is on quality. We have 60 community-based teams throughout the U.S., conducting approximately 15,000 health screening events a year. The CardioChek system does not require a venous draw, allowing us to deliver fast results so our teams can provide clients with immediate feedback."
Robert Huffstodt, President and CEO of PTS, Inc., is equally excited about the partnership. "Life Line Screening is a cutting-edge screening provider in the U.S. and abroad, and we are proud to have them implement our system around the world. They understand the role of preventive screening and have created a model that can deliver services on a global scale. This is very impressive and makes them a unique partner." The ability to use this system globally is an important component of this partnership. "CardioChek is in over 120 countries, by far the most in the business," said Kevin Luckow, Global Manager with Life Line Screening. "We are expanding our operations around the world, and they have the knowledge and experience in the intricacies of global business we ne